Immunomodulatory PEG-CRGD Hydrogels Promote Chondrogenic Differentiation of PBMSCs
Open Access
- 28 November 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2622
Abstract
Cartilage damage is a common injury. Currently, tissue engineering scaffolds with composite seed cells have emerged as a promising approach for cartilage repair. Polyethylene glycol (PEG) hydrogels are attractive tissue engineering scaffold materials as they have high water absorption capacity as well as nontoxic and nutrient transport properties. However, PEG is fundamentally bio-inert and lacks intrinsic cell adhesion capability, which is critical for the maintenance of cell function. Cell adhesion peptides are usually added to improve the cell adhesion capability of PEG-based hydrogels. The suitable cell adhesion peptide can not only improve cell adhesion capability, but also promote chondrogenesis and regulate the immune microenvironment. To improve the interactions between cells and PEG hydrogels, we designed cysteine-arginine-glycine-aspartic acid (CRGD), a cell adhesion peptide covalently cross-linked with PEG hydrogels by a Michael addition reaction, and explored the tissue-engineering hydrogels with immunomodulatory effects and promoted chondrogenic differentiation of mesenchymal stem cells (MSCs). The results indicated that CRGD improved the interaction between peripheral blood mesenchymal stem cells (PBMSCs) and PEG hydrogels. PEG hydrogels modified with 1 mM CRGD had the optimal capacity to promote chondrogenic differentiation, and CRGD could induce macrophage polarization towards the M2 phenotype to promote tissue regeneration and repair. PEG-CRGD hydrogels combined with PBMSCs have the potential to be suitable scaffolds for cartilage tissue engineering.Keywords
Funding Information
- National Natural Science Foundation of China (51920105006, 82102565, 52003008)
This publication has 36 references indexed in Scilit:
- Scaffold Mean Pore Size Influences Mesenchymal Stem Cell Chondrogenic Differentiation and Matrix DepositionTissue Engineering Part A, 2015
- Extracellular-Matrix-Based and Arg-Gly-Asp–Modified Photopolymerizing Hydrogels for Cartilage Tissue EngineeringTissue Engineering Part A, 2015
- A New Source of Mesenchymal Stem Cells for Articular Cartilage RepairThe American Journal of Sports Medicine, 2013
- Maximizing phenotype constraint and extracellular matrix production in primary human chondrocytes using arginine–glycine–aspartate concentration gradient hydrogelsActa Biomaterialia, 2013
- Injectable Biodegradable Poly(ethylene glycol)/RGD Peptide Hybrid Hydrogels for in vitro Chondrogenesis of Human Mesenchymal Stem CellsMacromolecular Rapid Communications, 2010
- The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalitiesBiomaterials, 2008
- Chondrogenic Differentiation Potential of Human Mesenchymal Stem Cells Photoencapsulated within Poly(Ethylene Glycol)–Arginine-Glycine-Aspartic Acid-Serine Thiol-Methacrylate Mixed-Mode NetworksTissue Engineering, 2007
- Chondrogenic Differentiation of Human Embryonic Stem Cell–Derived Cells in Arginine-Glycine-Aspartate–Modified HydrogelsTissue Engineering, 2006
- The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cellsBiomaterials, 2005
- Michael-Type Addition as a Tool for Surface FunctionalizationBioconjugate Chemistry, 2003